Seneca Therapeutics, Inc.
engineered T cell immunotherapies for cancer treatment
- Sector
- Biotech
- Headquarters
- BLUE BELL, PA
- Founded
- 2018
- Latest Form D
- $1.6M, Feb 2025
- Total capital
- $3M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $3M
- 5 Form D · last Feb 2025
- 21 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 15 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$1.6M
- Private capital raisedForm D · SEC · 4th filing$727K
- Private capital raisedForm D · SEC · 3rd filing$501K
- Private capital raisedForm D · SEC · 2nd filing$65K
- Private capital raisedForm D · SEC · 1st filing$55K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Cuong DoExecutive Officer, DirectorNamed in SEC Form D filings
- James HusseyExecutive Officer, DirectorNamed in SEC Form D filings
- Mark KerschnerExecutive Officer, DirectorNamed in SEC Form D filings
- Paul HallenbeckExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 15- PendingArmed Seneca Valley Virus Oncolytic Therapy Compositions And Methods ThereofUSPTOApplication 18272986
- PendingSeneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint InhibitorUSPTOApplication 18271619
- PendingCompositions And Methods Of Using Seneca Valley Virus (svv) For Treating CancerUSPTOApplication 17601768
Show all 15 patent records
- Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods ThereofSep 19, 2024 · Application 18272986Pending
- Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint InhibitorMar 28, 2024 · Application 18271619Pending
- Compositions And Methods Of Using Seneca Valley Virus (svv) For Treating CancerJun 30, 2022 · Application 17601768Pending
- Cancer Therapies With Oncolytic Virus And An Immune Checkpoint InhibitorApplication PCTUS2023073767Pending
- Cancer Therapies With Oncolytic Virus SVV-001 And Nivolumab For Screened PatientsApplication 63375049Pending
- Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods ThereofApplication PCTUS2022013001Pending
- Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint InhibitorApplication PCTUS2022011994Pending
- Armed Seneca Valley Virus Oncolytic Therapy Compositions And Methods ThereofApplication 63138999Pending
- Seneca Valley Virus Combination Therapy To Treat A Cancer Refractory To A Checkpoint InhibitorApplication 63135914Pending
- Second Generation Seneca Valley Virus Oncolytic Therapy: Compositions And Methods ThereofApplication PCTUS2020042795Pending
- Compositions And Methods Of Using Seneca Valley Virus (svv) For Treating CancerApplication PCTUS2020027784Pending
- Cancer Therapies With Oncolytic Virus And An Immune Checkpoint InhibitorApplication 19109726Pending
- Seneca Valley Virus MutantsApplication 19589558Pending
- Seneca Valley Virus MutantsApplication PCTUS2024057050Pending
- Seneca Valley Virus MutantsApplication 63602053Pending
Related companies, and why
- Enlaza TherapeuticsSimilar federal contract value in Biotech · null in contracts
- PAINREFORM LTD.Similar federal contract value in Biotech · null in contracts
- Isterian Biotech, Inc.Similar federal contract value in Biotech · null in contracts
- ABLi Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- ZBiotics CoSimilar federal contract value in Biotech · null in contracts
- GelMEDIX, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .